Inventor · disambiguated record
Susan Faas Mcknight
Also filed as: MCKNIGHT SUSAN F · MCKNIGHT SUSAN FAAS
7 granted patents·9 pending applications·29 citations·filing 2004–2023
81Inventor score
Top patents by PatentIndex Score
16 records- 0194US9494601B2Atypical hemolytic uremic syndrome (AHUS) biomarker proteinsALEXION PHARMA INC·Filed 2016·Granted Nov 15, 2016·14 cites·19 claims
- 0293US9658236B2Atypical hemolytic uremic syndrome (aHUS) biomarker proteinsALEXION PHARMA INC·Filed 2016·Granted May 23, 2017·11 cites·11 claims
- 0377US10126293B2Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disordersALEXION PHARMA INC·Filed 2017·Granted Nov 13, 2018·1 cites·4 claims
- 0474US12025621B2Atypical hemolytic uremic syndrome (AHUS) biomarker proteinsALEXION PHARMA INC·Filed 2021·Granted Jul 2, 2024·0 cites·22 claims
- 0574US11364284B2Methods of treating myointimal proliferationINOZYME PHARMA INC·Filed 2017·Granted Jun 21, 2022·2 cites·18 claims
- 0667US11459382B2Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patientsALEXION PHARMA INC·Filed 2018·Granted Oct 4, 2022·1 cites·17 claims
- 0765US11112402B2Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disordersALEXION PHARMA INC·Filed 2018·Granted Sep 7, 2021·0 cites·19 claims
- 0865US2025327070A1Compositions and methods for inhibiting complement factor bASTRAZENECA IRELAND LTD·Filed 2023·Application pending·0 cites
- 0963US2017269102A1Atypical hemolytic uremic syndrome (ahus) biomarker proteinsALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 1062US2015079613A1Atypical hemolytic uremic syndrome biomarker proteinsKITCHEL RYAN·Filed 2014·Application pending·0 cites
- 1161US2025002908A1Compositions and methods for inhibiting complement component 3 expressionASTRAZENECA IRELAND LTD·Filed 2022·Application pending·0 cites
- 1257US2022354933A1Methods of treating myointimal proliferationINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1357US2025199013A1Methods for detecting cm-tma biomarkersALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 1453US2007292416A1De-Immunized Anti-Cd3 AntibodyALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 1545US2007041972A1Antibodies and fusion proteins that include engineered constant regionsALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 1640US2016033514A1Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodiesALEXION PHARMA INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →